Literature DB >> 15162356

Tracheal mucormycosis presented as an intraluminal soft tissue mass.

Omer Wolf1, Ziv Gil, Leonor Leider-Trejo, Avi Khafif, Philippe Biderman, Dan M Fliss.   

Abstract

BACKGROUND: Mucormycosis is a potentially lethal disease caused by an opportunistic fungal infection. It occurs mostly in diabetic or immunosuppressed patients and usually involves the lungs or paranasal sinuses.
METHODS: We report a rare case of a patient with diabetic ketoacidosis who presented with progressive cough and dyspnea. CT of the neck and chest showed an intraluminal soft-tissue mass extending from the first tracheal ring to the thoracic inlet, causing severe destruction of the trachea. Direct laryngoscopy and biopsy demonstrated hyphal invasion with architecture typical of invasive mucormycosis.
RESULTS: The patient underwent resection of the upper trachea and prolonged amphotericin B therapy and is disease free at 24 months after surgery.
CONCLUSIONS: In patients with diabetes presenting with progressive hoarseness, dyspnea, and endobronchial mass, a fungal infection should be considered. In case of invasive tracheal mucormycosis, prompt diagnosis and early surgical resection may help improve survival. Copyright 2004 Wiley Periodicals, Inc. Head Neck 26: 541-543, 2004

Entities:  

Mesh:

Year:  2004        PMID: 15162356     DOI: 10.1002/hed.20055

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  Diagnosis and treatment of pulmonary mucormycosis: A case report.

Authors:  Zhiming Luo; Lin Zhang
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

Review 2.  Infections causing central airway obstruction: role of bronchoscopy in diagnosis and management.

Authors:  Sevak Keshishyan; Lawrence DeLorenzo; Kassem Hammoud; Arpine Avagyan; Hussein Assallum; Kassem Harris
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 3.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 4.  Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.

Authors:  Asim Azhar; Wajihul Hasan Khan; Parvez Anwar Khan; Khaled Alhosaini; Mohammad Owais; Aijaz Ahmad
Journal:  J Infect Public Health       Date:  2022-02-18       Impact factor: 3.718

5.  Subglottic mucormycosis in a COVID-19 patient: a rare case report.

Authors:  Behrooz Amirzargar; Mehrdad Jafari; Zahra Ahmadinejad; Mohammadreza Salehi; Sina Chalabi; Pouyan Aminishakib; Faeze Salahshoor; Sadegh Khodavaisy; Mohammadsadegh Zabihidan
Journal:  Oxf Med Case Reports       Date:  2022-07-26

6.  Tracheal, laryngeal and pulmonary mucormycosis followed by organizing pneumonia in a patient with Adult Onset Still's Disease.

Authors:  Fabian Leo; Michael Zeh; Annegret Prothmann; Oliver Kurzai; Sylke Kurz; Christian Grohé
Journal:  Med Mycol Case Rep       Date:  2018-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.